Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients
Background and Aim Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and i...
Saved in:
Published in | Journal of gastroenterology and hepatology Vol. 28; no. 9; pp. 1555 - 1564 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
Blackwell Publishing Ltd
01.09.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background and Aim
Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC).
Methods
The frequencies and phenotypes of CD4+CD25+CD127low/−CD49d− Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg‐cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real‐time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses.
Results
Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol‐anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor‐immuno‐related Gene Ontology terms were significantly affected.
Conclusions
Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression. |
---|---|
AbstractList | Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). The frequencies and phenotypes of CD4+CD25+CD127low/-CD49d- Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg-cell suppressive activity was determined using an in vitroCD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol-anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor-immuno-related Gene Ontology terms were significantly affected. Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression. Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). METHODS : The frequencies and phenotypes of CD4(+) CD25(+) CD127(low/-) CD49d(-) Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg-cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. RESULTS : Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol-anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor-immuno-related Gene Ontology terms were significantly affected. CONCLUSIONS : Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression. Background and Aim Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). Methods The frequencies and phenotypes of CD4+CD25+CD127low/−CD49d− Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg‐cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real‐time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. Results Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol‐anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor‐immuno‐related Gene Ontology terms were significantly affected. Conclusions Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression. Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). METHODS : The frequencies and phenotypes of CD4(+) CD25(+) CD127(low/-) CD49d(-) Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg-cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. RESULTS : Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol-anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor-immuno-related Gene Ontology terms were significantly affected. CONCLUSIONS : Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression.BACKGROUND AND AIMRegulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). METHODS : The frequencies and phenotypes of CD4(+) CD25(+) CD127(low/-) CD49d(-) Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg-cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. RESULTS : Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol-anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor-immuno-related Gene Ontology terms were significantly affected. CONCLUSIONS : Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression. |
Author | Wu, Han He, Hong-Wei Fan, Jia Liao, Rui Yi, Yong Sun, Jian Cheng, Yun-Feng Qiu, Shuang-Jian Cai, Xiao-Yan Wang, Jia-Xing Jin, Jian-Jun Li, Yi-Wei Chen, Pei |
Author_xml | – sequence: 1 givenname: Han surname: Wu fullname: Wu, Han organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 2 givenname: Pei surname: Chen fullname: Chen, Pei organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 3 givenname: Rui surname: Liao fullname: Liao, Rui organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 4 givenname: Yi-Wei surname: Li fullname: Li, Yi-Wei organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 5 givenname: Yong surname: Yi fullname: Yi, Yong organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 6 givenname: Jia-Xing surname: Wang fullname: Wang, Jia-Xing organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 7 givenname: Xiao-Yan surname: Cai fullname: Cai, Xiao-Yan organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 8 givenname: Hong-Wei surname: He fullname: He, Hong-Wei organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 9 givenname: Jian-Jun surname: Jin fullname: Jin, Jian-Jun organization: Biomedical Research Center, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 10 givenname: Yun-Feng surname: Cheng fullname: Cheng, Yun-Feng organization: Biomedical Research Center, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 11 givenname: Jia surname: Fan fullname: Fan, Jia organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 12 givenname: Jian surname: Sun fullname: Sun, Jian email: Shuang-Jian Qiu, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China. Email: andJian Sun, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China. , qiu.shuangjian@zs-hospital.sh.cnsun.jian1@zs-hospital.sh.cn organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China – sequence: 13 givenname: Shuang-Jian surname: Qiu fullname: Qiu, Shuang-Jian email: Shuang-Jian Qiu, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China. Email: andJian Sun, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China. , qiu.shuangjian@zs-hospital.sh.cnsun.jian1@zs-hospital.sh.cn organization: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23517245$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUtv1DAUhS1URKeFBX8AeQmLtH7FSZaoaqetqiJQEUvLsW8mLnlhO1Py7_EwbRdIILyxdPSdo3vvOUIHwzgAQm8pOaHpnd5v2hPKGGEv0IoKQTJaCHmAVqSkeVZxWh2ioxDuCSGCFPkrdMh4Tgsm8hVarobodZz70esOe9jMnY6jX_AdNtB1AT-42OLWbVrwePKw1R0MBrAeLE4ewGGekhyC2ybRRLd1ccFuwC1MKWiXkRI9NtobN4y9xkl2MMTwGr1sdBfgzeN_jL5enN-dXWY3n9ZXZx9vMsMryTJuJdHallUpWd7kFZCiEaxpZJk3FErKamltqTVQTWpbFya3tSyZ4EXBrDANP0bv97mTH3_MEKLqXdjNpQcY56Co4BVjJZPF_6CcyTQHSei7R3Sue7Bq8q7XflFPl03Ahz1g_BiCh-YZoUTtWlOpNfW7tcSe_sEaF9OZxl03rvuX48F1sPw9Wl2vL58c2d7hQoSfzw7tv6u0eZGrb7drJdkFW9MvQn3mvwD8T7la |
CitedBy_id | crossref_primary_10_18632_oncotarget_17340 crossref_primary_10_1016_j_jcyt_2018_06_002 crossref_primary_10_1016_j_critrevonc_2015_01_009 crossref_primary_10_1016_j_imbio_2021_152113 crossref_primary_10_1038_cmi_2016_4 crossref_primary_10_1002_lci2_22 crossref_primary_10_1002_lt_24050 crossref_primary_10_1111_vco_12383 crossref_primary_10_1111_bjh_17070 crossref_primary_10_1186_s43066_023_00250_2 crossref_primary_10_1016_j_canlet_2015_03_003 crossref_primary_10_1016_j_cdtm_2016_09_001 crossref_primary_10_1038_srep10665 crossref_primary_10_2174_1871520618666181114112431 crossref_primary_10_1186_2051_1426_2_S3_P240 crossref_primary_10_1155_2015_731469 |
Cites_doi | 10.1038/sj.bjc.6604149 10.1093/intimm/dxl060 10.1038/75556 10.1158/1078-0432.CCR-10-1073 10.1016/j.jneuroim.2010.10.015 10.1007/s00432-010-0833-8 10.1038/nm1292 10.1200/JCO.2008.18.7229 10.1016/j.jhep.2006.01.036 10.1186/1753-6561-3-s4-s11 10.1385/IR:32:1-3:031 10.4049/jimmunol.0900753 10.1128/IAI.00513-10 10.1016/j.jhep.2010.07.044 10.1002/hep.20644 10.1016/j.biocel.2007.03.022 10.1038/nri1026 10.1038/ni.1929 10.1016/j.exphem.2006.04.016 10.1158/0008-5472.CAN-08-2360 10.1038/nm1293 10.1038/nm1093 10.1084/jem.193.11.F41 10.1038/jid.2009.313 10.1126/science.1203486 10.1038/ni.1915 10.1182/blood-2008-04-150524 10.1158/1078-0432.CCR-07-0472 10.1200/JCO.2007.15.6521 10.4049/jimmunol.155.3.1151 10.1038/nature05673 10.1309/AJCP86PPBNGOHNNL 10.1111/j.1349-7006.2009.01182.x 10.1084/jem.20060772 10.1200/JCO.2006.09.4565 10.1158/1078-0432.CCR-08-1608 10.1016/j.gde.2007.12.007 10.1371/journal.pone.0008894 10.1038/nature01315 10.4049/jimmunol.0901099 10.1038/nri1806 10.1016/j.jim.2011.07.001 10.1007/s00262-007-0343-y 10.1111/j.1600-065X.2011.01007.x 10.1016/S0966-3274(02)00013-8 |
ContentType | Journal Article |
Copyright | 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. |
Copyright_xml | – notice: 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd – notice: 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 |
DOI | 10.1111/jgh.12202 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1440-1746 |
EndPage | 1564 |
ExternalDocumentID | 23517245 10_1111_jgh_12202 JGH12202 ark_67375_WNG_62F2G1R4_Q |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Key Sci‐Tech Special Project of China funderid: 2012ZX10002011‐002; 2012ZX10002010‐001‐002 – fundername: National Natural Science Foundation of China funderid: 81071707; 81071995; 81030038 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KMS LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 |
ID | FETCH-LOGICAL-c3962-3d60aad898625f59e07f42ff685f1e812b6dd8aae1a0bdb7c5db68243772d4cf3 |
IEDL.DBID | DR2 |
ISSN | 0815-9319 1440-1746 |
IngestDate | Fri Jul 11 00:54:48 EDT 2025 Fri Jul 11 11:51:58 EDT 2025 Mon Jul 21 05:25:04 EDT 2025 Tue Jul 01 01:45:03 EDT 2025 Thu Apr 24 23:11:32 EDT 2025 Wed Jan 22 16:53:04 EST 2025 Wed Oct 30 09:51:16 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | gene microarray immunosuppression tumor immuno-escape regulatory T cell hepatocellular carcinoma |
Language | English |
License | 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3962-3d60aad898625f59e07f42ff685f1e812b6dd8aae1a0bdb7c5db68243772d4cf3 |
Notes | National Natural Science Foundation of China - No. 81071707; No. 81071995; No. 81030038 National Key Sci-Tech Special Project of China - No. 2012ZX10002011-002; No. 2012ZX10002010-001-002 Figure S1 Hierarchical clustering of the 2.0-fold upregulated and downregulated genes in tumor-infiltrating Tregs (pooled samples) compared with peritumoral Tregs (pooled samples). T, tumor-infiltrating Treg cell; P, peritumoral Treg cell. Figure S2 Significant upregulated pathways in Tumor-infiltrating Tregs compared with peritumor using KEGG PATHWAY database. (a) Complement cascade pathway. (b) P53 signaling pathway. Upregulated genes are highlighted in red. Figure S3 Significantly changed glycosylation pathways in Tumor-infiltrating Tregs compared with peritumor using KEGG PATHWAY database. (a) Salivary secretion signaling pathway. Downregulated genes are highlighted in yellow. (b) Glycosylphosphatidylinositol-anchor biosynthesis signaling pathway. Upregulated genes are highlighted in red. Table S1 Primer sequence. Table S2 Complete list of differentially expressed genes of tumor-infiltrating Treg cells compared to peritumor. Table S3 Complete list of upregulated KEGG pathways based on the upregulated genes of tumor-infiltrating Treg cells compared to peritumor. Table S4 Complete list of downregulated KEGG pathways based on the downregulated genes of tumor-infiltrating Treg cells compared to peritumor. Table S5 Complete list of the upregulated GO terms based on the upregulated genes of tumor-infiltrating Treg cells compared to peritumor. Table S6 Complete list of the downregulated GO terms based on the downregulated genes of tumor-infiltrating Treg cells compared to peritumor. ArticleID:JGH12202 istex:3E65E1108F82E0C1915E7ECE7118A80213ABFE1D ark:/67375/WNG-62F2G1R4-Q ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 23517245 |
PQID | 1433266250 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1439228267 proquest_miscellaneous_1433266250 pubmed_primary_23517245 crossref_primary_10_1111_jgh_12202 crossref_citationtrail_10_1111_jgh_12202 wiley_primary_10_1111_jgh_12202_JGH12202 istex_primary_ark_67375_WNG_62F2G1R4_Q |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2013 |
PublicationDateYYYYMMDD | 2013-09-01 |
PublicationDate_xml | – month: 09 year: 2013 text: September 2013 |
PublicationDecade | 2010 |
PublicationPlace | Australia |
PublicationPlace_xml | – name: Australia |
PublicationTitle | Journal of gastroenterology and hepatology |
PublicationTitleAlternate | J Gastroenterol Hepatol |
PublicationYear | 2013 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr. Opin. Genet. Dev. 2008; 18: 11-18. Long ET, Baker S, Oliveira V, Sawitzki B, Wood KJ. Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice. PLoS ONE 2010; 5: e8894. Staun-Ram E, Miller A. Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-beta and role played in cell migration. J. Neuroimmunol. 2011; 232: 200-206. Bonnet A, Lagarrigue S, Liaubet L, Robert-Granie C, Sancristobal M, Tosser-Klopp G. Pathway results from the chicken data set using GOTM, Pathway Studio and Ingenuity softwares. BMC Proc. 2009; 3 (Suppl. 4): S11. Sugimoto N, Oida T, Hirota K et al. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 2006; 18: 1197-1209. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006; 6: 295-307. Salama P, Phillips M, Grieu F et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 2009; 27: 186-192. Quezada SA, Peggs KS, Simpson TR, Allison JP. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev. 2011; 241: 104-118. Hawiger D, Wan YY, Eynon EE, Flavell RA. The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsiveness. Nat. Immunol. 2010; 11: 962-968. Ju MJ, Qiu SJ, Gao Q et al. Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Sci. 2009; 100: 1267-1274. Ju MJ, Qiu SJ, Fan J et al. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am. J. Clin. Pathol. 2009; 131: 498-510. Unitt E, Rushbrook SM, Marshall A et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005; 41: 722-730. Kemper C, Verbsky JW, Price JD, Atkinson JP. T-cell stimulation and regulation: with complements from CD46. Immunol. Res. 2005; 32: 31-43. Liu D, Zhang T, Marshall AJ, Okkenhaug K, Vanhaesebroeck B, Uzonna JE. The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 2009; 183: 1921-1933. Gao Q, Qiu SJ, Fan J et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 2007; 25: 2586-2593. Li YW, Qiu SJ, Fan J et al. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 2011; 54: 497-505. Ruitenberg JJ, Boyce C, Hingorani R, Putnam A, Ghanekar SA. Rapid assessment of in vitro expanded human regulatory T cell function. J. Immunol. Methods 2011; 372: 95-106. Frentsch M, Arbach O, Kirchhoff D et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 2005; 11: 1118-1124. Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006; 203: 1701-1711. Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 2007; 13: 4345-4354. Croci DO, Zacarias Fluck MF, Rico MJ et al. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol. Immunother. 2007; 56: 1687-1700. Zhu XD, Zhang JB, Zhuang PY et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J. Clin. Oncol. 2008; 26: 2707-2716. Curiel TJ, Coukos G, Zou L et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004; 10: 942-949. Klein S, Kretz C, Krammer PH, Kuhn A. CD127low/- and FoxP3+expression levels characterize different regulatory T cell populations in human peripheral blood. J. Invest. Dermatol. 2010; 130: 492-499. Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000; 25: 25-29. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421: 388-392. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151-1164. Kleinewietfeld M, Starke M, Di Mitri D et al. CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. Blood 2009; 113: 827-836. Singh N, Yamamoto M, Takami M et al. CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis. J. Immunol. 2010; 184: 94-104. Ono M, Yaguchi H, Ohkura N et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007; 446: 685-689. Bach JF. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 2003; 3: 189-198. Truscott SM, Abate G, Price JD, Kemper C, Atkinson JP, Hoft DF. CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses. Infect. Immun. 2010; 78: 5295-5306. Loertscher R, Lavery P. The role of glycosyl phosphatidyl inositol (GPI)-anchored cell surface proteins in T-cell activation. Transpl. Immunol. 2002; 9: 93-96. Gao Q, Wang XY, Qiu SJ et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin. Cancer Res. 2009; 15: 971-979. Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat. Med. 2005; 11: 1113-1117. Mizukami Y, Kono K, Kawaguchi Y et al. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br. J. Cancer 2008; 98: 148-153. Shen X, Li N, Li H, Zhang T, Wang F, Li Q. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2010; 136: 1745-1754. Yang XH, Yamagiwa S, Ichida T et al. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J. Hepatol. 2006; 45: 254-262. Toledo F, Wahl GM. MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int. J. Biochem. Cell Biol. 2007; 39: 1476-1482. Jenner J, Kerst G, Handgretinger R, Muller I. Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells. Exp. Hematol. 2006; 34: 1212-1218. Deng L, Zhang H, Luan Y et al. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clin. Cancer Res. 2010; 16: 4105-4112. Gandhi R, Kumar D, Burns EJ et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat. Immunol. 2010; 11: 846-853. Gobert M, Treilleux I, Bendriss-Vermare N et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009; 69: 2000-2009. Shevach EM. Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. 2001; 193: F41-46. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565-1570. Marmor MD, Julius M. The function of GPI-anchored proteins in T cell development, activation and regulation of homeostasis. J. Biol. Regul. Homeost. Agents 2000; 14: 99-115. 2010; 78 2007; 39 2010; 11 2009; 69 2010; 16 2007; 446 2000; 25 2006; 34 2002; 9 2008; 18 2005; 41 2006; 18 2011; 54 2006; 6 2009; 113 2008; 98 2010; 184 1995; 155 2009; 131 2011; 372 2007; 56 2007; 13 2009; 27 2011; 331 2011; 232 2004; 10 2006; 45 2000; 14 2001; 193 2010; 136 2008; 26 2009; 100 2003; 3 2010; 130 2005; 32 2009; 183 2009; 3 2006; 203 2003; 421 2010; 5 2005; 11 2007; 25 2009; 15 2011; 241 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_42_1 e_1_2_6_43_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_40_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 Marmor MD (e_1_2_6_39_1) 2000; 14 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_28_1 e_1_2_6_45_1 e_1_2_6_27_1 e_1_2_6_46_1 e_1_2_6_26_1 e_1_2_6_47_1 |
References_xml | – reference: Gao Q, Qiu SJ, Fan J et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 2007; 25: 2586-2593. – reference: Croci DO, Zacarias Fluck MF, Rico MJ et al. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol. Immunother. 2007; 56: 1687-1700. – reference: Loertscher R, Lavery P. The role of glycosyl phosphatidyl inositol (GPI)-anchored cell surface proteins in T-cell activation. Transpl. Immunol. 2002; 9: 93-96. – reference: Klein S, Kretz C, Krammer PH, Kuhn A. CD127low/- and FoxP3+expression levels characterize different regulatory T cell populations in human peripheral blood. J. Invest. Dermatol. 2010; 130: 492-499. – reference: Frentsch M, Arbach O, Kirchhoff D et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 2005; 11: 1118-1124. – reference: Zhu XD, Zhang JB, Zhuang PY et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J. Clin. Oncol. 2008; 26: 2707-2716. – reference: Quezada SA, Peggs KS, Simpson TR, Allison JP. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev. 2011; 241: 104-118. – reference: Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006; 203: 1701-1711. – reference: Yang XH, Yamagiwa S, Ichida T et al. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J. Hepatol. 2006; 45: 254-262. – reference: Ju MJ, Qiu SJ, Fan J et al. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am. J. Clin. Pathol. 2009; 131: 498-510. – reference: Gandhi R, Kumar D, Burns EJ et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat. Immunol. 2010; 11: 846-853. – reference: Marmor MD, Julius M. The function of GPI-anchored proteins in T cell development, activation and regulation of homeostasis. J. Biol. Regul. Homeost. Agents 2000; 14: 99-115. – reference: Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 2007; 13: 4345-4354. – reference: Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421: 388-392. – reference: Singh N, Yamamoto M, Takami M et al. CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis. J. Immunol. 2010; 184: 94-104. – reference: Truscott SM, Abate G, Price JD, Kemper C, Atkinson JP, Hoft DF. CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses. Infect. Immun. 2010; 78: 5295-5306. – reference: Hawiger D, Wan YY, Eynon EE, Flavell RA. The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsiveness. Nat. Immunol. 2010; 11: 962-968. – reference: Long ET, Baker S, Oliveira V, Sawitzki B, Wood KJ. Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice. PLoS ONE 2010; 5: e8894. – reference: Kemper C, Verbsky JW, Price JD, Atkinson JP. T-cell stimulation and regulation: with complements from CD46. Immunol. Res. 2005; 32: 31-43. – reference: Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006; 6: 295-307. – reference: Ju MJ, Qiu SJ, Gao Q et al. Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Sci. 2009; 100: 1267-1274. – reference: Shen X, Li N, Li H, Zhang T, Wang F, Li Q. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2010; 136: 1745-1754. – reference: Bonnet A, Lagarrigue S, Liaubet L, Robert-Granie C, Sancristobal M, Tosser-Klopp G. Pathway results from the chicken data set using GOTM, Pathway Studio and Ingenuity softwares. BMC Proc. 2009; 3 (Suppl. 4): S11. – reference: Gao Q, Wang XY, Qiu SJ et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin. Cancer Res. 2009; 15: 971-979. – reference: Curiel TJ, Coukos G, Zou L et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004; 10: 942-949. – reference: Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565-1570. – reference: Jenner J, Kerst G, Handgretinger R, Muller I. Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells. Exp. Hematol. 2006; 34: 1212-1218. – reference: Kleinewietfeld M, Starke M, Di Mitri D et al. CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. Blood 2009; 113: 827-836. – reference: Shevach EM. Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. 2001; 193: F41-46. – reference: Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000; 25: 25-29. – reference: Liu D, Zhang T, Marshall AJ, Okkenhaug K, Vanhaesebroeck B, Uzonna JE. The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 2009; 183: 1921-1933. – reference: Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151-1164. – reference: Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr. Opin. Genet. Dev. 2008; 18: 11-18. – reference: Li YW, Qiu SJ, Fan J et al. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 2011; 54: 497-505. – reference: Toledo F, Wahl GM. MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int. J. Biochem. Cell Biol. 2007; 39: 1476-1482. – reference: Mizukami Y, Kono K, Kawaguchi Y et al. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br. J. Cancer 2008; 98: 148-153. – reference: Gobert M, Treilleux I, Bendriss-Vermare N et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009; 69: 2000-2009. – reference: Unitt E, Rushbrook SM, Marshall A et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005; 41: 722-730. – reference: Ruitenberg JJ, Boyce C, Hingorani R, Putnam A, Ghanekar SA. Rapid assessment of in vitro expanded human regulatory T cell function. J. Immunol. Methods 2011; 372: 95-106. – reference: Staun-Ram E, Miller A. Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-beta and role played in cell migration. J. Neuroimmunol. 2011; 232: 200-206. – reference: Sugimoto N, Oida T, Hirota K et al. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 2006; 18: 1197-1209. – reference: Deng L, Zhang H, Luan Y et al. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clin. Cancer Res. 2010; 16: 4105-4112. – reference: Bach JF. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 2003; 3: 189-198. – reference: Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat. Med. 2005; 11: 1113-1117. – reference: Salama P, Phillips M, Grieu F et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 2009; 27: 186-192. – reference: Ono M, Yaguchi H, Ohkura N et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007; 446: 685-689. – volume: 372 start-page: 95 year: 2011 end-page: 106 article-title: Rapid assessment of in vitro expanded human regulatory T cell function publication-title: J. Immunol. Methods – volume: 18 start-page: 11 year: 2008 end-page: 18 article-title: Immune surveillance: a balance between protumor and antitumor immunity publication-title: Curr. Opin. Genet. Dev. – volume: 421 start-page: 388 year: 2003 end-page: 392 article-title: Activation of human CD4+ cells with CD3 and CD46 induces a T‐regulatory cell 1 phenotype publication-title: Nature – volume: 25 start-page: 25 year: 2000 end-page: 29 article-title: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium publication-title: Nat. Genet. – volume: 11 start-page: 1113 year: 2005 end-page: 1117 article-title: A live‐cell assay to detect antigen‐specific CD4+ T cells with diverse cytokine profiles publication-title: Nat. Med. – volume: 331 start-page: 1565 year: 2011 end-page: 1570 article-title: Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion publication-title: Science – volume: 15 start-page: 971 year: 2009 end-page: 979 article-title: Overexpression of PD‐L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma publication-title: Clin. Cancer Res. – volume: 9 start-page: 93 year: 2002 end-page: 96 article-title: The role of glycosyl phosphatidyl inositol (GPI)‐anchored cell surface proteins in T‐cell activation publication-title: Transpl. Immunol. – volume: 3 start-page: 189 year: 2003 end-page: 198 article-title: Regulatory T cells under scrutiny publication-title: Nat. Rev. Immunol. – volume: 184 start-page: 94 year: 2010 end-page: 104 article-title: CD4(+)CD25(+) regulatory T cells resist a novel form of CD28‐ and Fas‐dependent p53‐induced T cell apoptosis publication-title: J. Immunol. – volume: 155 start-page: 1151 year: 1995 end-page: 1164 article-title: Immunologic self‐tolerance maintained by activated T cells expressing IL‐2 receptor alpha‐chains (CD25). Breakdown of a single mechanism of self‐tolerance causes various autoimmune diseases publication-title: J. Immunol. – volume: 203 start-page: 1701 year: 2006 end-page: 1711 article-title: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 T reg cells publication-title: J. Exp. Med. – volume: 45 start-page: 254 year: 2006 end-page: 262 article-title: Increase of CD4+ CD25+ regulatory T‐cells in the liver of patients with hepatocellular carcinoma publication-title: J. Hepatol. – volume: 69 start-page: 2000 year: 2009 end-page: 2009 article-title: Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome publication-title: Cancer Res. – volume: 193 start-page: F41 year: 2001 end-page: 46 article-title: Certified professionals: CD4(+)CD25(+) suppressor T cells publication-title: J. Exp. Med. – volume: 25 start-page: 2586 year: 2007 end-page: 2593 article-title: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection publication-title: J. Clin. Oncol. – volume: 100 start-page: 1267 year: 2009 end-page: 1274 article-title: Combination of peritumoral mast cells and T‐regulatory cells predicts prognosis of hepatocellular carcinoma publication-title: Cancer Sci. – volume: 98 start-page: 148 year: 2008 end-page: 153 article-title: Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer publication-title: Br. J. Cancer – volume: 34 start-page: 1212 year: 2006 end-page: 1218 article-title: Increased alpha2,6‐sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells publication-title: Exp. Hematol. – volume: 41 start-page: 722 year: 2005 end-page: 730 article-title: Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T‐regulatory cells publication-title: Hepatology – volume: 14 start-page: 99 year: 2000 end-page: 115 article-title: The function of GPI‐anchored proteins in T cell development, activation and regulation of homeostasis publication-title: J. Biol. Regul. Homeost. Agents – volume: 113 start-page: 827 year: 2009 end-page: 836 article-title: CD49d provides access to “untouched” human Foxp3+ Treg free of contaminating effector cells publication-title: Blood – volume: 446 start-page: 685 year: 2007 end-page: 689 article-title: Foxp3 controls regulatory T‐cell function by interacting with AML1/Runx1 publication-title: Nature – volume: 11 start-page: 1118 year: 2005 end-page: 1124 article-title: Direct access to CD4+ T cells specific for defined antigens according to CD154 expression publication-title: Nat. Med. – volume: 27 start-page: 186 year: 2009 end-page: 192 article-title: Tumor‐infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer publication-title: J. Clin. Oncol. – volume: 241 start-page: 104 year: 2011 end-page: 118 article-title: Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication publication-title: Immunol. Rev. – volume: 26 start-page: 2707 year: 2008 end-page: 2716 article-title: High expression of macrophage colony‐stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma publication-title: J. Clin. Oncol. – volume: 5 start-page: e8894 year: 2010 article-title: Alpha‐1,2‐mannosidase and hence N‐glycosylation are required for regulatory T cell migration and allograft tolerance in mice publication-title: PLoS ONE – volume: 32 start-page: 31 year: 2005 end-page: 43 article-title: T‐cell stimulation and regulation: with complements from CD46 publication-title: Immunol. Res. – volume: 6 start-page: 295 year: 2006 end-page: 307 article-title: Regulatory T cells, tumour immunity and immunotherapy publication-title: Nat. Rev. Immunol. – volume: 11 start-page: 962 year: 2010 end-page: 968 article-title: The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell‐mediated peripheral T cell unresponsiveness publication-title: Nat. Immunol. – volume: 11 start-page: 846 year: 2010 end-page: 853 article-title: Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell‐like and Foxp3(+) regulatory T cells publication-title: Nat. Immunol. – volume: 183 start-page: 1921 year: 2009 end-page: 1933 article-title: The p110delta isoform of phosphatidylinositol 3‐kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells publication-title: J. Immunol. – volume: 13 start-page: 4345 year: 2007 end-page: 4354 article-title: A unique subset of CD4 CD25 Foxp3 T cells secreting interleukin‐10 and transforming growth factor‐beta1 mediates suppression in the tumor microenvironment publication-title: Clin. Cancer Res. – volume: 136 start-page: 1745 year: 2010 end-page: 1754 article-title: Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma publication-title: J. Cancer Res. Clin. Oncol. – volume: 232 start-page: 200 year: 2011 end-page: 206 article-title: Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon‐beta and role played in cell migration publication-title: J. Neuroimmunol. – volume: 56 start-page: 1687 year: 2007 end-page: 1700 article-title: Dynamic cross‐talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment publication-title: Cancer Immunol. Immunother. – volume: 131 start-page: 498 year: 2009 end-page: 510 article-title: Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection publication-title: Am. J. Clin. Pathol. – volume: 3 start-page: S11 year: 2009 article-title: Pathway results from the chicken data set using GOTM, Pathway Studio and Ingenuity softwares publication-title: BMC Proc. – volume: 16 start-page: 4105 year: 2010 end-page: 4112 article-title: Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients publication-title: Clin. Cancer Res. – volume: 39 start-page: 1476 year: 2007 end-page: 1482 article-title: MDM2 and MDM4: p53 regulators as targets in anticancer therapy publication-title: Int. J. Biochem. Cell Biol. – volume: 18 start-page: 1197 year: 2006 end-page: 1209 article-title: Foxp3‐dependent and ‐independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis publication-title: Int. Immunol. – volume: 10 start-page: 942 year: 2004 end-page: 949 article-title: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival publication-title: Nat. Med. – volume: 130 start-page: 492 year: 2010 end-page: 499 article-title: CD127low/‐ and FoxP3+expression levels characterize different regulatory T cell populations in human peripheral blood publication-title: J. Invest. Dermatol. – volume: 54 start-page: 497 year: 2011 end-page: 505 article-title: Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection publication-title: J. Hepatol. – volume: 78 start-page: 5295 year: 2010 end-page: 5306 article-title: CD46 engagement on human CD4+ T cells produces T regulatory type 1‐like regulation of antimycobacterial T cell responses publication-title: Infect. Immun. – ident: e_1_2_6_15_1 doi: 10.1038/sj.bjc.6604149 – ident: e_1_2_6_45_1 doi: 10.1093/intimm/dxl060 – ident: e_1_2_6_23_1 doi: 10.1038/75556 – ident: e_1_2_6_17_1 doi: 10.1158/1078-0432.CCR-10-1073 – ident: e_1_2_6_38_1 doi: 10.1016/j.jneuroim.2010.10.015 – ident: e_1_2_6_30_1 doi: 10.1007/s00432-010-0833-8 – ident: e_1_2_6_27_1 doi: 10.1038/nm1292 – ident: e_1_2_6_18_1 doi: 10.1200/JCO.2008.18.7229 – ident: e_1_2_6_29_1 doi: 10.1016/j.jhep.2006.01.036 – ident: e_1_2_6_24_1 doi: 10.1186/1753-6561-3-s4-s11 – ident: e_1_2_6_31_1 doi: 10.1385/IR:32:1-3:031 – ident: e_1_2_6_35_1 doi: 10.4049/jimmunol.0900753 – ident: e_1_2_6_33_1 doi: 10.1128/IAI.00513-10 – volume: 14 start-page: 99 year: 2000 ident: e_1_2_6_39_1 article-title: The function of GPI‐anchored proteins in T cell development, activation and regulation of homeostasis publication-title: J. Biol. Regul. Homeost. Agents – ident: e_1_2_6_9_1 doi: 10.1016/j.jhep.2010.07.044 – ident: e_1_2_6_21_1 doi: 10.1002/hep.20644 – ident: e_1_2_6_34_1 doi: 10.1016/j.biocel.2007.03.022 – ident: e_1_2_6_25_1 doi: 10.1038/nri1026 – ident: e_1_2_6_44_1 doi: 10.1038/ni.1929 – ident: e_1_2_6_36_1 doi: 10.1016/j.exphem.2006.04.016 – ident: e_1_2_6_16_1 doi: 10.1158/0008-5472.CAN-08-2360 – ident: e_1_2_6_28_1 doi: 10.1038/nm1293 – ident: e_1_2_6_14_1 doi: 10.1038/nm1093 – ident: e_1_2_6_26_1 doi: 10.1084/jem.193.11.F41 – ident: e_1_2_6_46_1 doi: 10.1038/jid.2009.313 – ident: e_1_2_6_3_1 doi: 10.1126/science.1203486 – ident: e_1_2_6_43_1 doi: 10.1038/ni.1915 – ident: e_1_2_6_47_1 doi: 10.1182/blood-2008-04-150524 – ident: e_1_2_6_13_1 doi: 10.1158/1078-0432.CCR-07-0472 – ident: e_1_2_6_7_1 doi: 10.1200/JCO.2007.15.6521 – ident: e_1_2_6_11_1 doi: 10.4049/jimmunol.155.3.1151 – ident: e_1_2_6_42_1 doi: 10.1038/nature05673 – ident: e_1_2_6_8_1 doi: 10.1309/AJCP86PPBNGOHNNL – ident: e_1_2_6_10_1 doi: 10.1111/j.1349-7006.2009.01182.x – ident: e_1_2_6_20_1 doi: 10.1084/jem.20060772 – ident: e_1_2_6_6_1 doi: 10.1200/JCO.2006.09.4565 – ident: e_1_2_6_19_1 doi: 10.1158/1078-0432.CCR-08-1608 – ident: e_1_2_6_2_1 doi: 10.1016/j.gde.2007.12.007 – ident: e_1_2_6_37_1 doi: 10.1371/journal.pone.0008894 – ident: e_1_2_6_32_1 doi: 10.1038/nature01315 – ident: e_1_2_6_41_1 doi: 10.4049/jimmunol.0901099 – ident: e_1_2_6_12_1 doi: 10.1038/nri1806 – ident: e_1_2_6_22_1 doi: 10.1016/j.jim.2011.07.001 – ident: e_1_2_6_4_1 doi: 10.1007/s00262-007-0343-y – ident: e_1_2_6_5_1 doi: 10.1111/j.1600-065X.2011.01007.x – ident: e_1_2_6_40_1 doi: 10.1016/S0966-3274(02)00013-8 |
SSID | ssj0004075 |
Score | 2.1904693 |
Snippet | Background and Aim
Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different... Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1555 |
SubjectTerms | Adult Antigens, Surface - analysis B-Lymphocyte Subsets - immunology Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - immunology Carcinoma, Hepatocellular - pathology Case-Control Studies Female Gene Expression Profiling - methods Gene Expression Regulation, Neoplastic gene microarray hepatocellular carcinoma Humans Immune Tolerance - immunology Immunophenotyping immunosuppression Liver Neoplasms - genetics Liver Neoplasms - immunology Liver Neoplasms - pathology Lymphocytes, Tumor-Infiltrating - immunology Male Middle Aged Oligonucleotide Array Sequence Analysis - methods regulatory T cell T-Lymphocytes, Regulatory - immunology Tumor Escape - immunology tumor immuno-escape |
Title | Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients |
URI | https://api.istex.fr/ark:/67375/WNG-62F2G1R4-Q/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.12202 https://www.ncbi.nlm.nih.gov/pubmed/23517245 https://www.proquest.com/docview/1433266250 https://www.proquest.com/docview/1439228267 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEF5KBfHFeu-pF1YR8SWHZDebZPFJxHOOBQuWFvsghL2lR2qTQy5i_fXObC5aqSK-hTBJ9jKzM7P59htCnmfcaC1dEXAdZUFsiijQEq5SCe6mcODxjUf5HiSr43j_RJxskVfjWZieH2LacEPL8Os1GrjSza9GfrqeR4x5IknEamFAdPiTOiruSXbB44lAgp4NrEIexTM-eckXXcNh_XZVoHk5bvWOZ7FDPo1N7vEmZ_Ou1XPz_Tc2x__s0y1ycwhI6eteg26TLVfeIdffD7_c75KLd7j923bneJSf1n3p-qq-oEcUN_0biju5dO3hInRTI3s4LhZUlZYiiJc23aYH236Fm6YvVkE_l3QNjrCt8B2IhKUGixqV1bmiA9Vrc48cL94evVkFQ72GwHCZsIDbJFTKZhKyJFEI6cK0iFlRJJkoIgeRhE6szZRykQq11akRVicZMiKmzIKa8Ptku6xKt0soJFmWOSYTGaexkwbyWM2l4JZxaZQKZ-TlOHO5GcjMsabGl3xKak7XuR_KGXk2iW56Bo-rhF746Z8kVH2GkLdU5B8PlnnCFmwZHcb5hxl5OupHDoaIg6RKV3UN5FAcQmHoefhXGckgyU3SGXnQK9f0RcYFBJOxgK55FflzY_P95cpf7P276ENyg_lCHoiOe0S227pzjyGcavUTbzc_ACPAG64 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKKwEX3tDlaRCgXrJKnKcPHBBlH32sRLUVvQXbcXar0mSVB7D8Jv4K_4kZJxsoKohLD9ysaOT4MeOZcb58Q8jzyFVScp1arnQiy1OpY0kOrZCDu0k1eHxlUL6TYHTo7Rz5R2vk2-pfmIYfortwQ8sw5zUaOF5I_2rls3nfYZC8t5DKXb38DAlb-Wq8Dbv7grHB2-mbkdXWFLCUywNmuUlgC5FEHCJ5P_W5tsPUY2kaRH7qaPB2MkiSSAjtCFsmMlR-IoMIWftClsBUXOj3EtnACuLI1L998JOsymtofcHH-hYHzW55jAxuaDXUM95vAzfyy3mh7dlI2bi6wXXyfbVIDcLlpF9Xsq--_sYf-b-s4g1yrY256evGSG6SNZ3dIpf3W1TBbbIc4w13VZ8iWwEt9AxLmuXFkk4pftcoKV5W07lBxNBFgQTpeB5SkSUUccq0rBcNnvgTPFRNPQ56nNE5-Poqxz4Q7EsV1m3K8lNBWzbb8g45vJCJ3yXrWZ7pTUIhj0yYZjzgXuhpriBVly733YS5XAlh98jWSlVi1fK1Y9mQj3GXt83msdm6HnnWiS4akpLzhF4afeskRHGCqL7Qj99PhnHABmzoHHjxux55ulLIGM4aXCSR6bwuIU10IdqHmdt_leEM8vgg7JF7jTZ3b2SuD_Gy58PUjE7-ebDxznBkGvf_XfQJuTKa7u_Fe-PJ7gNylZm6JQgGfEjWq6LWjyB6rORjY7SUfLho_f4B1Wl6yw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JbtRAEG2FRIq4sC_D2iBAXDyyu731gQNimCWBEUSJyM305hkUYo-8AMMv8St8FNXtBYIC4pIDt5ZVavdS1VXVfn6F0KOYSiGYTh0qvNjxZeo5gkErYuBuUg0eX1qU7zycHvg7h8HhBvrW_QvT8EP0F27GMux5bQx8pdJfjXyxHHoEcvcWUbmr158hXyufzUawuY8JGb_cfzF12pICjqQsJA5Vocu5ihkE8kEaMO1GqU_SNIyD1NPg7ESoVMy59rgrlIhkoEQYG9K-iCiYCYV-z6EtP3SZqRMx2vvJVeU3rL7gYgOHgWK3NEYWNtQN9YTz2zL7-OW0yPZkoGw93fgi-t6tUQNwORrWlRjKr7_RR_4ni3gJXWgjbvy8MZHLaENnV9D26xZTcBWtZ-Z-u6qPDVcBLvTCFDTLizXex-arRonNVTVeWjwMXhWGHt2chphnChuUMi7rVYMm_gQPZVONA3_I8BI8fZWbPgzUF0tTtSnLjzluuWzLa-jgTCZ-HW1meaZvIgxZpCKasJD5ka-ZhERdUBZQRSiTnLsD9LTTlES2bO2maMjHpM_aFsvEbt0APexFVw1FyWlCT6y69RK8ODKYvihI3s0nSUjGZOLt-cnbAXrQ6WMCJ41ZJJ7pvC4hSaQQ68PM3b_KMAJZfBgN0I1Gmfs3EhpAtOwHMDWrkn8ebLIzmdrGrX8XvY-234zGyavZfPc2Ok9s0RKDBLyDNqui1nchdKzEPWuyGL0_a_X-Ad4reXo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intratumoral+regulatory+T+cells+with+higher+prevalence+and+more+suppressive+activity+in+hepatocellular+carcinoma+patients&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Wu%2C+Han&rft.au=Chen%2C+Pei&rft.au=Liao%2C+Rui&rft.au=Li%2C+Yi%E2%80%90Wei&rft.date=2013-09-01&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=28&rft.issue=9&rft.spage=1555&rft.epage=1564&rft_id=info:doi/10.1111%2Fjgh.12202&rft.externalDBID=10.1111%252Fjgh.12202&rft.externalDocID=JGH12202 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon |